Opera Trading Capital’s Allergan plc AGN.PRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-12,500
Closed -$9.54M 136
2016
Q4
$9.54M Buy
+12,500
New +$9.45M 2.87% 7
2016
Q2
Sell
-19,000
Closed -$17.5M 142
2016
Q1
$17.5M Buy
+19,000
New +$18.2M 4.58% 4

Other funds holding AGN.PRA

Opera Trading Capital's AGN.PRA Position: Q1 2017 in Review

Opera Trading Capital sold out of Allergan plc (AGN.PRA) in Q1 2017, closing a stake of 12,500 shares — an estimated $9.54M sold.

Opera Trading Capital first reported a position in AGN.PRA in Q1 2016 and held it in 2 quarters. The position peaked at $17.5M in Q1 2016. 106 funds tracked by Wall St. Rank hold AGN.PRA as of Q1 2017.

  • Opera Trading Capital reported no remaining Allergan plc position as of Q1 2017 after selling out during the quarter.
  • Opera Trading Capital sold 12,500 Allergan plc shares in Q1 2017, an estimated $9.54M.
  • Opera Trading Capital first reported a position in Allergan plc in Q1 2016 and held it in 2 quarters.
  • Opera Trading Capital's Allergan plc position peaked at $17.5M in Q1 2016.
  • 106 funds tracked by Wall St. Rank held Allergan plc as of Q1 2017.

Based on Opera Trading Capital's 13F filing for Q1 2017, filed 3 May 2017.